Secteur Krystal Biotech, Inc.

Actions

KRYS

US5011471027

Produits pharmaceutiques

Marché Fermé - 22:00:00 21/09/2026 Varia. 5j. Varia. 1 janv.
333,85 USD -0,84% Graphique intraday de Krystal Biotech, Inc. -1,82% +35,41%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-0,84%-1,82%-3,67%-4,08%+35,41%+104,10%+181,09%+493,83% - 9,88 Md
+1,70%+0,56%-4,30%+30,86%+3,41%+34,83%-3,06%+23,37%+96,34% 79,7 Md
+12,27%+17,89%+19,16%+170,39%+486,44%+585,18%+72,54%-60,16% - 69,04 Md
+1,36%+3,71%+6,87%+60,10%+4,67%-9,30%-28,33%-42,15%+73,82% 60,82 Md
+0,29%-1,27%-9,61%+2,04%-17,29%-10,95%+28,43%-2,27% - 47,16 Md
-0,28%+0,76%-3,86%-14,58%-11,36%+2,42%+157,55%+122,07%+192,77% 46,38 Md
+1,66%+0,79%+1,06%+11,44%+24,48%+53,73%-15,39%-25,87%-29,79% 32,37 Md
-0,53%+2,01%-2,47%+26,91%+26,20%+44,05%+111,95%+63,88%+43,76% 25,27 Md
+0,68%+8,53%+3,62%+36,83%+35,21%+8,87%+175,30%+48,03% - 22,72 Md
+0,29%+1,23%-1,55%+0,04%+33,71%+58,03%+102,46%+86,11%+315,89% 15,7 Md
-0,05%-8,01%-18,31%+0,47%-12,96%+27,13%+146,87%+32,68% - 13,02 Md
+0,59%-1,92%-20,31%-6,22%-26,25%-29,84%+333,33%+397,25%+5 735,70% 12,92 Md
+0,19%-3,54%-3,96%+17,13%+7,79%+17,84%-25,74%-18,03%-34,34% 12,4 Md
-1,10%-5,12%-1,10%-17,97%+12,51%+77,22%+174,98%+558,41%+2 558,34% 10,76 Md
-0,69%+23,06%+13,90%+89,39%+422,79%+494,59%+742,63%+38,21% - 10,4 Md
+0,41%-0,72%-2,87%+6,32%-10,32%-19,43%-22,27%-56,46%-50,83% 6,56 Md
+3,61%+3,18%+4,34%+25,93%+4,89%+0,66%+66,20%-9,10% - 6,35 Md
+1,15%+2,02%-1,14%+41,77%+89,41%+120,58%+355,83%+561,00% - 6,1 Md
+4,13%+5,40%-11,54%+4,98%+2,60%+17,53%+178,82%+207,12% - 5,64 Md
-2,61%+4,62%-6,31%+4,23%-30,65%-45,76%+149,55%+108,84%+95,23% 5,47 Md
Moyenne +0,46%+2,45%-2,10%+24,30%+54,04%+76,58%+144,14%+126,34%+817,90% 24,93 Md
Moyenne pondérée par Capi. +0,48%+3,61%+0,49%+41,18%+81,04%+107,95%+82,57%+50,73%+413,79%
  1. Bourse
  2. Actions
  3. Action KRYS
  4. Secteur Krystal Biotech, Inc.
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT